Mark Benjamin

Executive Officer at Cyrus Biotechnology.

Raised on Cyrus Biotechnology filings

$1.5M

of $3M offered across 1 Form D filing

Form D filings: 1
Teammates: 6
Last filing: May 8, 2026

Company

Cyrus Biotechnology

Biotech · Seattle, WA

Computational protein design for drug discovery

Computational protein design for drug discovery

Investors: 17
Still open: $1.5M

Investors: 17
Sector: Biotech
HQ: Seattle, WA

Cyrus Biotechnology filings

Cyrus Biotechnology Form D filings
Filed	Security	Sold of offered	Filing
May 8, 2026	Security to be acquired	$1.5M/ $3M	Form D/A

Security to be acquiredFiled May 8, 2026Form D/A
$1.5M/ $3M

Works with

Also named on Cyrus Biotechnology filings

Lucas NivonChief Executive Officer, Form D signerForm D signer Jason SmithDirector Anthony ManningDirector Chad WaiteDirector Ramakrishna SatyavoluDirector Yifan SongDirector